PULSed Field Ablation for Atrial Fibrillation Using a Balloon for Early Intervention - Study

This study is a prospective, multicenter, randomized, open-label, blinded end-point, controlled clinical trial to investigate the impact of first line pulsed field ablation during 12 months follow-up in patients with early-stage paroxysmal or persistent atrial fibrillation (\<3 years) compared to usual care, defined as OMT.

NCT Number	NCT07621003
Lead Sponsor	Asklepios proresearch Collaborators: Atrial Fibrillation Network, Abbott
Conditions	Atrial Fibrillation
Enrollment	264 participants
Start Date	2026-08-17
Primary Completion	2030-03-31 (estimated)
Study Completion	2031-03-31 (estimated)
Updated on ClinicalTrials.gov	2026-08-12